ProShares - UltraShort Nasdaq Biotechnology (BIS) Dividend Yield, History & Forecast

ProShares - UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 6.51% ($0.79 per share annually (TTM)). The most recent ex-dividend date was June 24, 2026, with payment scheduled for June 30, 2026. market capitalization is approximately $2M. Review BIS dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

BIS fund composition

BIS holds 8 positions. It charges an expense ratio of 3.20%, and manages $2.0M.

Sector allocation

Cash & Others100.0%

Frequently Asked Questions about ProShares - UltraShort Nasdaq Biotechnology (BIS)

What is ProShares - UltraShort Nasdaq Biotechnology's dividend yield?
ProShares - UltraShort Nasdaq Biotechnology (BIS) pays a current trailing twelve-month dividend yield of 6.51%, which works out to $0.79 per share annually based on the most recent payout schedule.
When does ProShares - UltraShort Nasdaq Biotechnology pay distributions?
The most recent ex-dividend date was June 24, 2026. The next scheduled dividend payment date is June 30, 2026.
What does ProShares - UltraShort Nasdaq Biotechnology invest in?
The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses.